Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance

Clin Exp Dermatol. 2021 Dec;46(8):1596-1597. doi: 10.1111/ced.14797. Epub 2021 Jul 29.

Authors

V Kharkar¹, T Vishwanath¹, S Mahajan¹, R Joshi², P Gole¹

Affiliations

¹ Department of Dermatology, Seth G. S. Medical College and K. E. M. Hospital, Mumbai, India.
² Department of Dermatology, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
COVID-19 / diagnosis
COVID-19 / epidemiology
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / adverse effects*
Dermoscopy / methods
Eosinophils / immunology*
Eosinophils / pathology
Female
Histamine Antagonists / therapeutic use
Humans
Purpura / diagnosis
Purpura / etiology
SARS-CoV-2 / genetics
SARS-CoV-2 / immunology
Skin Diseases, Vascular / chemically induced*
Skin Diseases, Vascular / pathology
Treatment Outcome
Vasculitis, Leukocytoclastic, Cutaneous / diagnosis
Vasculitis, Leukocytoclastic, Cutaneous / etiology*

Substances

COVID-19 Vaccines
Histamine Antagonists